Highlights for the quarter ended 31 December 2017
• Net revenue increased to US$1.8 million compared to US$0.2 million in Q4 2016; driven by
U.S. and Australia sales growth
• U.S. unit sales grew 56% compared to Q3 2017
• AeroForm available in more than one hundred and forty (140) hospitals across the US
• Cash and short-term investments balance as of 31 December 2017 of US$22.6 million
Ann: Appendix 4C, page-2
-
- There are more pages in this discussion • 58 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AXP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.824M | |||
| Open | High | Low | Value | Volume |
| 0.1¢ | 0.1¢ | 0.1¢ | $141 | 141.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 11611805 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 70378896 | 57 |
View Market Depth
| Last trade - 15.59pm 27/09/2024 (20 minute delay) ? |
| AXP (ASX) Chart |